Oric Pharmaceuticals (ORIC) Cash from Operations (2019 - 2026)
Oric Pharmaceuticals' (ORIC) quarterly Cash from Operations came in at 32438000.0 in Q1 2026, little changed YoY from 32343553.21 in Q1 2025, and down 44.28% on a QoQ basis from 22483000.0 in Q4 2025.
Oric Pharmaceuticals (ORIC) Cash from Operations (2019 - 2026) Analysis & Trends
Oric Pharmaceuticals (ORIC) has 8 years of Cash from Operations data on file, last reported at 32438000.0 in Q1 2026.
- Quarterly Cash from Operations changed 0.29% year-over-year to 32438000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 110875000.0 (up 3.59% YoY) and the FY2025 annual result came in at 110970000.0, up 1.5% from the prior year.
- Cash from Operations fell to 32438000.0 in Q1 2026, from 22483000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 15329000.0 in Q4 2022 to a low of 32533000.0 in Q1 2025.
- A 5-year average of 24523588.24 and a median of 24270000.0 in 2023 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2022 — Cash from Operations plunged 59.12% — and 2025, when it gained 19.86%.
- Tracing ORIC's Cash from Operations over 5 years: stood at 15329000.0 in 2022, then tumbled by 58.33% to 24270000.0 in 2023, then fell by 15.59% to 28054000.0 in 2024, then rose by 19.86% to 22483000.0 in 2025, then plunged by 44.28% to 32438000.0 in 2026.
- The last three Cash from Operations figures came in at 32438000.0 (Q1 2026), 22483000.0 (Q4 2025), and 25112000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -387.32 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 462.82 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 728.46 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 326.72 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Oric Pharmaceuticals | 1.44 Bn | 1.44 Bn | - | -31.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -31.61 Mn |
| Jun 30, 2026 | -31.61 Mn |
| Mar 31, 2026 | -32.44 Mn |
| Mar 31, 2026 | -32.44 Mn |
| Dec 31, 2025 | -22.48 Mn |
| Dec 31, 2025 | -22.48 Mn |
| Sep 30, 2025 | -25.11 Mn |
| Sep 30, 2025 | -25.11 Mn |
| Jun 30, 2025 | -30.84 Mn |
| Jun 30, 2025 | -30.84 Mn |
| Mar 31, 2025 | -32.53 Mn |
| Mar 31, 2025 | -32.53 Mn |
| Dec 31, 2024 | -28.05 Mn |
| Dec 31, 2024 | -28.05 Mn |
| Sep 30, 2024 | -28.80 Mn |
| Sep 30, 2024 | -28.80 Mn |
| Jun 30, 2024 | -25.63 Mn |
| Jun 30, 2024 | -25.63 Mn |
| Mar 31, 2024 | -30.19 Mn |
| Mar 31, 2024 | -30.19 Mn |